These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression. Kuppuswamy M; Spencer JF; Doronin K; Tollefson AE; Wold WS; Toth K Gene Ther; 2005 Nov; 12(22):1608-17. PubMed ID: 16034456 [TBL] [Abstract][Full Text] [Related]
24. Cancer gene-therapy: clinical trials. Palmer DH; Young LS; Mautner V Trends Biotechnol; 2006 Feb; 24(2):76-82. PubMed ID: 16380178 [TBL] [Abstract][Full Text] [Related]
25. Herpes simplex virus 1 (HSV-1) for cancer treatment. Shen Y; Nemunaitis J Cancer Gene Ther; 2006 Nov; 13(11):975-92. PubMed ID: 16604059 [TBL] [Abstract][Full Text] [Related]
26. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis. Dorer DE; Nettelbeck DM Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376 [TBL] [Abstract][Full Text] [Related]
29. Bacterial infections associated with cancer: possible implication in etiology with special reference to lateral gene transfer. Khan AA; Shrivastava A Cancer Metastasis Rev; 2010 Jun; 29(2):331-7. PubMed ID: 20401627 [TBL] [Abstract][Full Text] [Related]
30. Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery. Thorne SH; Contag CH Gene Ther; 2008 May; 15(10):753-8. PubMed ID: 18356814 [TBL] [Abstract][Full Text] [Related]
31. In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies. Lamikanra A; Myers KA; Ferris N; Mitrophanous KA; Carroll MW Gene Ther; 2005 Jun; 12(12):988-98. PubMed ID: 15772687 [TBL] [Abstract][Full Text] [Related]
32. Fighting cancer with vaccinia virus: teaching new tricks to an old dog. Shen Y; Nemunaitis J Mol Ther; 2005 Feb; 11(2):180-95. PubMed ID: 15668130 [TBL] [Abstract][Full Text] [Related]
33. Bacterial vectors for imaging and cancer gene therapy: a review. Cronin M; Stanton RM; Francis KP; Tangney M Cancer Gene Ther; 2012 Nov; 19(11):731-40. PubMed ID: 22996740 [TBL] [Abstract][Full Text] [Related]
34. Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy. Yang ZR; Wang HF; Zhao J; Peng YY; Wang J; Guinn BA; Huang LQ Cancer Gene Ther; 2007 Jul; 14(7):599-615. PubMed ID: 17479105 [TBL] [Abstract][Full Text] [Related]
36. Gene therapy of cancer in the clinic: good news in sight from Asia? Favaro E; Indraccolo S Curr Opin Mol Ther; 2007 Oct; 9(5):477-82. PubMed ID: 17932811 [TBL] [Abstract][Full Text] [Related]
37. Oncolytic virotherapy for cancer treatment: challenges and solutions. Davis JJ; Fang B J Gene Med; 2005 Nov; 7(11):1380-9. PubMed ID: 16025557 [TBL] [Abstract][Full Text] [Related]
39. DNA vaccination and gene therapy: optimization and delivery for cancer therapy. Bodles-Brakhop AM; Draghia-Akli R Expert Rev Vaccines; 2008 Sep; 7(7):1085-101. PubMed ID: 18767956 [TBL] [Abstract][Full Text] [Related]
40. Bacteria-related spontaneous and therapeutic remission of human malignancies. Nagorsen D; Marincola FM; Kaiser HE In Vivo; 2002; 16(6):551-6. PubMed ID: 12494900 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]